Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic ...
JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an ...
Prime Medicine’s strategy to efficiently develop Prime Editors for genetic liver diseases. The Wilson’s Disease treatment landscape, patient experience and global market opportunity, for which there ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...
Latest] Global Distilled Water Market Size/Share Worth USD 925.5 Million by 2034 at a 8.4% CAGR: Custom Market Insights ...
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced achievement of ...
Given the success of the Research Topic ‘Impact of oral and gut microbiome on health and diseases’ Volume I and the rapidly evolving subject area, we are ...
As part of the 8th International Symposium on Membrane Technologies and Applications (MEMTEK 2025), to be held on November 12 ...
Since 2019, breakthroughs in synthetic biology, AI-driven protein design, and precision fermentation have revitalized the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback